Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins

References

• DeBusk FL. The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. J Pediatr 1972; 80:697 - 724; http://dx.doi.org/10.1016/S0022-3476(72)80229-4; PMID: 4552697
   PubMed Web of Science ®Google Scholar
• Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 2008; 358:592 - 604; http://dx.doi.org/10.1056/NEJMoa0706898; PMID: 18256394
   PubMed Web of Science ®Google Scholar
• Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003; 423:293 - 8; http://dx.doi.org/10.1038/nature01629; PMID: 12714972
   PubMed Web of Science ®Google Scholar
• De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003; 300:2055; http://dx.doi.org/10.1126/science.1084125; PMID: 12702809
   PubMed Web of Science ®Google Scholar
• McKeon FD, Kirschner MW, Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 1986; 319:463 - 8; http://dx.doi.org/10.1038/319463a0; PMID: 3453101
   PubMed Web of Science ®Google Scholar
• Aebi U, Cohn J, Buhle L, Gerace L. The nuclear lamina is a meshwork of intermediate-type filaments. Nature 1986; 323:560 - 4; http://dx.doi.org/10.1038/323560a0; PMID: 3762708
   PubMed Web of Science ®Google Scholar
• Goldman AE, Maul G, Steinert PM, Yang HY, Goldman RD. Keratin-like proteins that coisolate with intermediate filaments of BHK-21 cells are nuclear lamins. Proc Natl Acad Sci U S A 1986; 83:3839 - 43; http://dx.doi.org/10.1073/pnas.83.11.3839; PMID: 2424013
   PubMed Web of Science ®Google Scholar
• Fisher DZ, Chaudhary N, Blobel G. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci U S A 1986; 83:6450 - 4; http://dx.doi.org/10.1073/pnas.83.17.6450; PMID: 3462705
   PubMed Web of Science ®Google Scholar
• Lin F, Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 1993; 268:16321 - 6; PMID: 8344919
   PubMed Web of Science ®Google Scholar
• Sinensky M, Fantle K, Trujillo M, McLain T, Kupfer A, Dalton MJ. The processing pathway of prelamin A. J Cell Sci 1994; 107:61 - 7; PMID: 8175923
   PubMed Web of Science ®Google Scholar
• Davies BS, Fong LG, Yang SH, Coffinier C, Young SG. The posttranslational processing of prelamin A and disease. Annu Rev Genomics Hum Genet 2009; 10:153 - 74; http://dx.doi.org/10.1146/annurev-genom-082908-150150; PMID: 19453251
   PubMed Web of Science ®Google Scholar
• Corrigan DP, Kuszczak D, Rusinol AE, Thewke DP, Hrycyna CA, Michaelis S, et al. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem J 2005; 387:129 - 38; http://dx.doi.org/10.1042/BJ20041359; PMID: 15479156
   PubMed Web of Science ®Google Scholar
• Davies BS, Coffinier C, Yang SH, Barnes RH 2nd, Jung HJ, Young SG, et al. Investigating the purpose of prelamin A processing. Nucleus 2011; 2:4 - 9; http://dx.doi.org/10.4161/nucl.2.1.13723; PMID: 21647293
   PubMed Web of Science ®Google Scholar
• Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 2004; 101:8963 - 8; http://dx.doi.org/10.1073/pnas.0402943101; PMID: 15184648
   PubMed Web of Science ®Google Scholar
• Bridger JM, Kill IR. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 2004; 39:717 - 24; http://dx.doi.org/10.1016/j.exger.2004.02.002; PMID: 15130666
   PubMed Web of Science ®Google Scholar
• Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, Sandoval S, et al. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci U S A 2005; 102:10291 - 6; http://dx.doi.org/10.1073/pnas.0504641102; PMID: 16014412
   PubMed Web of Science ®Google Scholar
• Toth JI, Yang SH, Qiao X, Beigneux AP, Gelb MH, Moulson CL, et al. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc Natl Acad Sci U S A 2005; 102:12873 - 8; http://dx.doi.org/10.1073/pnas.0505767102; PMID: 16129834
   PubMed Web of Science ®Google Scholar
• Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, et al. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 2005; 102:12879 - 84; http://dx.doi.org/10.1073/pnas.0506001102; PMID: 16129833
   PubMed Web of Science ®Google Scholar
• Mallampalli MP, Huyer G, Bendale P, Gelb MH, Michaelis S. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 2005; 102:14416 - 21; http://dx.doi.org/10.1073/pnas.0503712102; PMID: 16186497
   PubMed Web of Science ®Google Scholar
• Glynn MW, Glover TW. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet 2005; 14:2959 - 69; http://dx.doi.org/10.1093/hmg/ddi326; PMID: 16126733
   PubMed Web of Science ®Google Scholar
• McClintock D, Gordon LB, Djabali K. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci U S A 2006; 103:2154 - 9; http://dx.doi.org/10.1073/pnas.0511133103; PMID: 16461887
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 2005; 11:440 - 5; http://dx.doi.org/10.1038/nm1204; PMID: 15750600
   PubMed Web of Science ®Google Scholar
• Paradisi M, McClintock D, Boguslavsky RL, Pedicelli C, Worman HJ, Djabali K. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress. BMC Cell Biol 2005; 6:27; http://dx.doi.org/10.1186/1471-2121-6-27; PMID: 15982412
   PubMed Web of Science ®Google Scholar
• Huang S, Chen L, Libina N, Janes J, Martin GM, Campisi J, et al. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference. Hum Genet 2005; 118:444 - 50; http://dx.doi.org/10.1007/s00439-005-0051-7; PMID: 16208517
   PubMed Web of Science ®Google Scholar
• Liu Y, Rusiñol A, Sinensky M, Wang Y, Zou Y. DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J Cell Sci 2006; 119:4644 - 9; http://dx.doi.org/10.1242/jcs.03263; PMID: 17062639
   PubMed Web of Science ®Google Scholar
• Verstraeten VL, Ji JY, Cummings KS, Lee RT, Lammerding J. Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors. Aging Cell 2008; 7:383 - 93; http://dx.doi.org/10.1111/j.1474-9726.2008.00382.x; PMID: 18331619
   PubMed Web of Science ®Google Scholar
• Wang Y, Panteleyev AA, Owens DM, Djabali K, Stewart CL, Worman HJ. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin. Hum Mol Genet 2008; 17:2357 - 69; http://dx.doi.org/10.1093/hmg/ddn136; PMID: 18442998
   PubMed Web of Science ®Google Scholar
• Fong LG, Vickers TA, Farber EA, Choi C, Yun UJ, Hu Y, et al. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides. Hum Mol Genet 2009; 18:2462 - 71; http://dx.doi.org/10.1093/hmg/ddp184; PMID: 19376814
   PubMed Web of Science ®Google Scholar
• Yang SH, Qiao X, Farber E, Chang SY, Fong LG, Young SG. Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele. J Biol Chem 2008; 283:7094 - 9; http://dx.doi.org/10.1074/jbc.M708138200; PMID: 18178963
   PubMed Web of Science ®Google Scholar
• Wang Y, Östlund C, Worman HJ. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome. Nucleus 2010; 1:432 - 9; PMID: 21326826
   PubMed Web of Science ®Google Scholar
• Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 2011; 3:89ra58; http://dx.doi.org/10.1126/scitranslmed.3002346; PMID: 21715679
   PubMed Web of Science ®Google Scholar
• Yang SH, Meta M, Qiao X, Frost D, Bauch J, Coffinier C, et al. A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest 2006; 116:2115 - 21; http://dx.doi.org/10.1172/JCI28968; PMID: 16862216
   PubMed Web of Science ®Google Scholar
• Yang SH, Qiao X, Fong LG, Young SG. Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation. Biochim Biophys Acta 2008; 1781:36 - 9; http://dx.doi.org/10.1016/j.bbalip.2007.11.003; PMID: 18082640
   PubMed Web of Science ®Google Scholar
• Yang SH, Andres DA, Spielmann HP, Young SG, Fong LG. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J Clin Invest 2008; 118:3291 - 300; http://dx.doi.org/10.1172/JCI35876; PMID: 18769635
   PubMed Web of Science ®Google Scholar
• Capell BC, Olive M, Erdos MR, Cao K, Faddah DA, Tavarez UL, et al. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci U S A 2008; 105:15902 - 7; http://dx.doi.org/10.1073/pnas.0807840105; PMID: 18838683
   PubMed Web of Science ®Google Scholar
• Yang SH, Chang SY, Andres DA, Spielmann HP, Young SG, Fong LG. Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria. J Lipid Res 2010; 51:400 - 5; http://dx.doi.org/10.1194/jlr.M002808; PMID: 19965595
   PubMed Web of Science ®Google Scholar
• Yang SH, Chang SY, Ren S, Wang Y, Andres DA, Spielmann HP, et al. Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin. Hum Mol Genet 2011; 20:436 - 44; http://dx.doi.org/10.1093/hmg/ddq490; PMID: 21088111
   PubMed Web of Science ®Google Scholar
• Young SG, Fong LG, Michaelis S. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res 2005; 46:2531 - 58; http://dx.doi.org/10.1194/jlr.R500011-JLR200; PMID: 16207929
   PubMed Web of Science ®Google Scholar
• Dahl KN, Scaffidi P, Islam MF, Yodh AG, Wilson KL, Misteli T. Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 2006; 103:10271 - 6; http://dx.doi.org/10.1073/pnas.0601058103; PMID: 16801550
   PubMed Web of Science ®Google Scholar
• Holtz D, Tanaka RA, Hartwig J, McKeon F. The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope. Cell 1989; 59:969 - 77; http://dx.doi.org/10.1016/0092-8674(89)90753-8; PMID: 2557160
   PubMed Web of Science ®Google Scholar
• Lutz RJ, Trujillo MA, Denham KS, Wenger L, Sinensky M. Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina. Proc Natl Acad Sci U S A 1992; 89:3000 - 4; http://dx.doi.org/10.1073/pnas.89.7.3000; PMID: 1557405
   PubMed Web of Science ®Google Scholar
• Kieran MW, Gordon L, Kleinman M. New approaches to progeria. Pediatrics 2007; 120:834 - 41; http://dx.doi.org/10.1542/peds.2007-1356; PMID: 17908771
   PubMed Web of Science ®Google Scholar
• Pereira S, Bourgeois P, Navarro C, Esteves-Vieira V, Cau P, De Sandre-Giovannoli A, et al. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. Mech Ageing Dev 2008; 129:449 - 59; http://dx.doi.org/10.1016/j.mad.2008.04.003; PMID: 18513784
   PubMed Web of Science ®Google Scholar
• Verstraeten VL, Peckham LA, Olive M, Capell BC, Collins FS, Nabel EG, et al. Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect. Proc Natl Acad Sci U S A 2011; 108:4997 - 5002; http://dx.doi.org/10.1073/pnas.1019532108; PMID: 21383178
   PubMed Web of Science ®Google Scholar
• Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999; 147:913 - 20; http://dx.doi.org/10.1083/jcb.147.5.913; PMID: 10579712
   PubMed Web of Science ®Google Scholar
• De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002; 70:726 - 36; http://dx.doi.org/10.1086/339274; PMID: 11799477
   PubMed Web of Science ®Google Scholar
• Bonne G, Di Barletta MR, Varnous S, Bécane HM, Hammouda EH, Merlini L, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999; 21:285 - 8; http://dx.doi.org/10.1038/6799; PMID: 10080180
   PubMed Web of Science ®Google Scholar
• Walter MC, Witt TN, Weigel BS, Reilich P, Richard P, Pongratz D, et al. Deletion of the LMNA initiator codon leading to a neurogenic variant of autosomal dominant Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 2005; 15:40 - 4; http://dx.doi.org/10.1016/j.nmd.2004.09.007; PMID: 15639119
   PubMed Web of Science ®Google Scholar
• Dalton MB, Fantle KS, Bechtold HA, DeMaio L, Evans RM, Krystosek A, et al. The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization. Cancer Res 1995; 55:3295 - 304; PMID: 7614464
   PubMed Web of Science ®Google Scholar
• Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J, Okada R, et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet 1996; 12:254 - 9; http://dx.doi.org/10.1038/ng0396-254; PMID: 8589715
   PubMed Web of Science ®Google Scholar
• Manilal S, Nguyen TM, Sewry CA, Morris GE. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet 1996; 5:801 - 8; http://dx.doi.org/10.1093/hmg/5.6.801; PMID: 8776595
   PubMed Web of Science ®Google Scholar
• Östlund C, Ellenberg J, Hallberg E, Lippincott-Schwartz J, Worman HJ. Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. J Cell Sci 1999; 112:1709 - 19; PMID: 10318763
   PubMed Web of Science ®Google Scholar
• Fairley EA, Kendrick-Jones J, Ellis JA. The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane. J Cell Sci 1999; 112:2571 - 82; PMID: 10393813
   PubMed Web of Science ®Google Scholar
• Holt I, Östlund C, Stewart CL, Man N, Worman HJ, Morris GE. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo. J Cell Sci 2003; 116:3027 - 35; http://dx.doi.org/10.1242/jcs.00599; PMID: 12783988
   PubMed Web of Science ®Google Scholar
• Shimi T, Pfleghaar K, Kojima S, Pack CG, Solovei I, Goldman AE, et al. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev 2008; 22:3409 - 21; http://dx.doi.org/10.1101/gad.1735208; PMID: 19141474
   PubMed Web of Science ®Google Scholar
• Ye Q, Worman HJ. Protein-protein interactions between human nuclear lamins expressed in yeast. Exp Cell Res 1995; 219:292 - 8; http://dx.doi.org/10.1006/excr.1995.1230; PMID: 7628545
   PubMed Web of Science ®Google Scholar
• Schirmer EC, Gerace L. The stability of the nuclear lamina polymer changes with the composition of lamin subtypes according to their individual binding strengths. J Biol Chem 2004; 279:42811 - 7; http://dx.doi.org/10.1074/jbc.M407705200; PMID: 15284226
   PubMed Web of Science ®Google Scholar
• Delbarre E, Tramier M, Coppey-Moisan M, Gaillard C, Courvalin JC, Buendia B. The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers. Hum Mol Genet 2006; 15:1113 - 22; http://dx.doi.org/10.1093/hmg/ddl026; PMID: 16481358
   PubMed Web of Science ®Google Scholar
• Ostlund C, Sullivan T, Stewart CL, Worman HJ. Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins. Biochemistry 2006; 45:1374 - 82; http://dx.doi.org/10.1021/bi052156n; PMID: 16445279
   PubMedGoogle Scholar
• Östlund C, Folker ES, Choi JC, Gomes ER, Gundersen GG, Worman HJ. Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins. J Cell Sci 2009; 122:4099 - 108; http://dx.doi.org/10.1242/jcs.057075; PMID: 19843581
   PubMed Web of Science ®Google Scholar
• Cance WG, Chaudhary N, Worman HJ, Blobel G, Cordon-Cardo C. Expression of the nuclear lamins in normal and neoplastic human tissues. J Exp Clin Cancer Res 1992; 11:233 - 46
   Web of Science ®Google Scholar
• Goodchild RE, Dauer WT. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J Cell Biol 2005; 168:855 - 62; http://dx.doi.org/10.1083/jcb.200411026; PMID: 15767459
   PubMed Web of Science ®Google Scholar
• Sharma GG, Hwang KK, Pandita RK, Gupta A, Dhar S, Parenteau J, et al. Human heterochromatin protein 1 isoforms HP1(Hsalpha) and HP1(Hsbeta) interfere with hTERT-telomere interactions and correlate with changes in cell growth and response to ionizing radiation. Mol Cell Biol 2003; 23:8363 - 76; http://dx.doi.org/10.1128/MCB.23.22.8363-8376.2003; PMID: 14585993
   PubMed Web of Science ®Google Scholar
• Fong LG, Frost D, Meta M, Qiao X, Yang SH, Coffinier C, et al. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 2006; 311:1621 - 3; http://dx.doi.org/10.1126/science.1124875; PMID: 16484451
   PubMed Web of Science ®Google Scholar
• Roszik J, Szöllosi J, Vereb G. AccPbFRET: an ImageJ plugin for semi-automatic, fully corrected analysis of acceptor photobleaching FRET images. BMC Bioinformatics 2008; 9:346; http://dx.doi.org/10.1186/1471-2105-9-346; PMID: 18713453
   PubMed Web of Science ®Google Scholar